Global Lancets Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Lancets Market
The global Lancets market size is projected to reach US$ 2522.8 million by 2027, from US$ 1661 million in 2020, at a CAGR of 5.7% during 2021-2027.
Global Lancets Scope and Segment
The global Lancets market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Safety Lancets
Homecare Lancets
By the end users/application, this report covers the following segments
Cholesterol Tests
Glucose Tests
Others
Competitive Landscape:
The report provides a list of all the key players in the Lancets market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Lancets key manufacturers in this market include:
Roche
Lifescan
BD
Bayer
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical

TABLE OF CONTENT

1 Lancets Market Overview
1.1 Lancets Product Overview
1.2 Lancets Market Segment by Type
1.2.1 Safety Lancets
1.2.2 Homecare Lancets
1.3 Global Lancets Market Size by Type
1.3.1 Global Lancets Market Size Overview by Type (2016-2027)
1.3.2 Global Lancets Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Lancets Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Lancets Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Lancets Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Lancets Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Lancets Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Lancets Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Lancets Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lancets Sales Breakdown by Type (2016-2030)
1.4.2 Europe Lancets Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Lancets Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Lancets Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Lancets Sales Breakdown by Type (2016-2030)

2 Global Lancets Market Competition by Company
2.1 Global Top Players by Lancets Sales (2016-2030)
2.2 Global Top Players by Lancets Revenue (2016-2030)
2.3 Global Top Players Lancets Price (2016-2030)
2.4 Global Top Manufacturers Lancets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lancets Market Competitive Situation and Trends
2.5.1 Lancets Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Lancets Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lancets as of 2020)
2.7 Date of Key Manufacturers Enter into Lancets Market
2.8 Key Manufacturers Lancets Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Lancets Status and Outlook by Region
3.1 Global Lancets Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Lancets Historic Market Size by Region
3.2.1 Global Lancets Sales in Volume by Region (2016-2030)
3.2.2 Global Lancets Sales in Value by Region (2016-2030)
3.2.3 Global Lancets Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Lancets Forecasted Market Size by Region
3.3.1 Global Lancets Sales in Volume by Region (2022-2027)
3.3.2 Global Lancets Sales in Value by Region (2022-2027)
3.3.3 Global Lancets Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Lancets by Application
4.1 Lancets Market Segment by Application
4.1.1 Cholesterol Tests
4.1.2 Glucose Tests
4.1.3 Others
4.2 Global Lancets Market Size by Application
4.2.1 Global Lancets Market Size Overview by Application (2016-2027)
4.2.2 Global Lancets Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Lancets Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Lancets Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Lancets Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Lancets Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Lancets Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Lancets Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Lancets Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lancets Sales Breakdown by Application (2016-2030)
4.3.2 Europe Lancets Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Lancets Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Lancets Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Lancets Sales Breakdown by Application (2016-2030)

5 North America Lancets by Country
5.1 North America Lancets Historic Market Size by Country
5.1.1 North America Lancets Sales in Volume by Country (2016-2030)
5.1.2 North America Lancets Sales in Value by Country (2016-2030)
5.2 North America Lancets Forecasted Market Size by Country
5.2.1 North America Lancets Sales in Volume by Country (2022-2027)
5.2.2 North America Lancets Sales in Value by Country (2022-2027)

6 Europe Lancets by Country
6.1 Europe Lancets Historic Market Size by Country
6.1.1 Europe Lancets Sales in Volume by Country (2016-2030)
6.1.2 Europe Lancets Sales in Value by Country (2016-2030)
6.2 Europe Lancets Forecasted Market Size by Country
6.2.1 Europe Lancets Sales in Volume by Country (2022-2027)
6.2.2 Europe Lancets Sales in Value by Country (2022-2027)

7 Asia-Pacific Lancets by Region
7.1 Asia-Pacific Lancets Historic Market Size by Region
7.1.1 Asia-Pacific Lancets Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Lancets Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Lancets Forecasted Market Size by Region
7.2.1 Asia-Pacific Lancets Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Lancets Sales in Value by Region (2022-2027)

8 Latin America Lancets by Country
8.1 Latin America Lancets Historic Market Size by Country
8.1.1 Latin America Lancets Sales in Volume by Country (2016-2030)
8.1.2 Latin America Lancets Sales in Value by Country (2016-2030)
8.2 Latin America Lancets Forecasted Market Size by Country
8.2.1 Latin America Lancets Sales in Volume by Country (2022-2027)
8.2.2 Latin America Lancets Sales in Value by Country (2022-2027)

9 Middle East and Africa Lancets by Country
9.1 Middle East and Africa Lancets Historic Market Size by Country
9.1.1 Middle East and Africa Lancets Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Lancets Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Lancets Forecasted Market Size by Country
9.2.1 Middle East and Africa Lancets Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Lancets Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Lancets Business
10.1 Roche
10.1.1 Roche Corporation Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Lancets Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Roche Lancets Products Offered
10.1.5 Roche Recent Development
10.2 Lifescan
10.2.1 Lifescan Corporation Information
10.2.2 Lifescan Introduction and Business Overview
10.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Lifescan Lancets Products Offered
10.2.5 Lifescan Recent Development
10.3 BD
10.3.1 BD Corporation Information
10.3.2 BD Introduction and Business Overview
10.3.3 BD Lancets Sales, Revenue and Gross Margin (2016-2030)
10.3.4 BD Lancets Products Offered
10.3.5 BD Recent Development
10.4 Bayer
10.4.1 Bayer Corporation Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Lancets Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Bayer Lancets Products Offered
10.4.5 Bayer Recent Development
10.5 Abbott
10.5.1 Abbott Corporation Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Abbott Lancets Products Offered
10.5.5 Abbott Recent Development
10.6 B. Braun
10.6.1 B. Braun Corporation Information
10.6.2 B. Braun Introduction and Business Overview
10.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2016-2030)
10.6.4 B. Braun Lancets Products Offered
10.6.5 B. Braun Recent Development
10.7 ARKRAY
10.7.1 ARKRAY Corporation Information
10.7.2 ARKRAY Introduction and Business Overview
10.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2016-2030)
10.7.4 ARKRAY Lancets Products Offered
10.7.5 ARKRAY Recent Development
10.8 Terumo
10.8.1 Terumo Corporation Information
10.8.2 Terumo Introduction and Business Overview
10.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Terumo Lancets Products Offered
10.8.5 Terumo Recent Development
10.9 I-SENS
10.9.1 I-SENS Corporation Information
10.9.2 I-SENS Introduction and Business Overview
10.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2016-2030)
10.9.4 I-SENS Lancets Products Offered
10.9.5 I-SENS Recent Development
10.10 Nipro
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Lancets Product Category, Application and Specification
10.10.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Nipro Recent Development
10.11 Omron
10.11.1 Omron Corporation Information
10.11.2 Omron Introduction and Business Overview
10.11.3 Omron Lancets Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Omron Lancets Products Offered
10.11.5 Omron Recent Development
10.12 Infopia
10.12.1 Infopia Corporation Information
10.12.2 Infopia Introduction and Business Overview
10.12.3 Infopia Lancets Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Infopia Lancets Products Offered
10.12.5 Infopia Recent Development
10.13 AgaMatrix
10.13.1 AgaMatrix Corporation Information
10.13.2 AgaMatrix Introduction and Business Overview
10.13.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2016-2030)
10.13.4 AgaMatrix Lancets Products Offered
10.13.5 AgaMatrix Recent Development
10.14 Smiths Medical
10.14.1 Smiths Medical Corporation Information
10.14.2 Smiths Medical Introduction and Business Overview
10.14.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2016-2030)
10.14.4 Smiths Medical Lancets Products Offered
10.14.5 Smiths Medical Recent Development
10.15 Sarstedt
10.15.1 Sarstedt Corporation Information
10.15.2 Sarstedt Introduction and Business Overview
10.15.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2016-2030)
10.15.4 Sarstedt Lancets Products Offered
10.15.5 Sarstedt Recent Development
10.16 SANNUO
10.16.1 SANNUO Corporation Information
10.16.2 SANNUO Introduction and Business Overview
10.16.3 SANNUO Lancets Sales, Revenue and Gross Margin (2016-2030)
10.16.4 SANNUO Lancets Products Offered
10.16.5 SANNUO Recent Development
10.17 Yicheng
10.17.1 Yicheng Corporation Information
10.17.2 Yicheng Introduction and Business Overview
10.17.3 Yicheng Lancets Sales, Revenue and Gross Margin (2016-2030)
10.17.4 Yicheng Lancets Products Offered
10.17.5 Yicheng Recent Development
10.18 Yuwell
10.18.1 Yuwell Corporation Information
10.18.2 Yuwell Introduction and Business Overview
10.18.3 Yuwell Lancets Sales, Revenue and Gross Margin (2016-2030)
10.18.4 Yuwell Lancets Products Offered
10.18.5 Yuwell Recent Development
10.19 Greiner Bio One
10.19.1 Greiner Bio One Corporation Information
10.19.2 Greiner Bio One Introduction and Business Overview
10.19.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2016-2030)
10.19.4 Greiner Bio One Lancets Products Offered
10.19.5 Greiner Bio One Recent Development
10.20 Edan
10.20.1 Edan Corporation Information
10.20.2 Edan Introduction and Business Overview
10.20.3 Edan Lancets Sales, Revenue and Gross Margin (2016-2030)
10.20.4 Edan Lancets Products Offered
10.20.5 Edan Recent Development
10.21 Narang Medical
10.21.1 Narang Medical Corporation Information
10.21.2 Narang Medical Introduction and Business Overview
10.21.3 Narang Medical Lancets Sales, Revenue and Gross Margin (2016-2030)
10.21.4 Narang Medical Lancets Products Offered
10.21.5 Narang Medical Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lancets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lancets Industrial Chain Analysis
11.4 Lancets Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lancets Distributors
12.3 Lancets Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample